Analyst Ratings for Intercept Pharmaceuticals (ICPT)

ICPT Rating Summary

  |   Expand Research on ICPT
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.9 / 10   Percentile Rank: 38%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/27/2023 H.C. Wainwright Ed Arce Downgrade Neutral
(Buy)
19.00
(N/A)
18.71
(19.00)
1.55% Details
9/27/2023 Canaccord Edward Nash Downgrade Hold
(Buy)
19.00
(N/A)
10.44
(19.00)
81.99% Details